COMMUNIQUÉS West-GlobeNewswire

Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
04/09/2025
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) announced today that it will now present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 7:00 a.m. ET [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
04/09/2025
CONSHOHOCKEN, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
04/09/2025
CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company [...]
Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders
04/09/2025
FORT MILL, S.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac [...]
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2025
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt [...]
ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
04/09/2025
SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, will participate in the Morgan Stanley 23rd [...]
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
04/09/2025
Results from long-term follow up of patients treated with atrioventricular interval modulation (“AVIM”) therapy show blood pressure-lowering effects are sustained for years after activation, reversible with no observed [...]
MD Logic Health and Dr. Roxanne Carfora Launch Advanced Cholesterol Support: A Doctor-Created Formula for Heart and Metabolic Wellness
04/09/2025
Miami, Florida , Sept. 04, 2025 (GLOBE NEWSWIRE) -- MD Logic Health® , a trusted leader in science-backed wellness solutions, has partnered with Dr. Roxanne Carfora, D.O., P.C. , a Board Certified Anti-Aging and [...]
Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc.
04/09/2025
Medtimo Inc. will help Biorad Medisys expand its market reach, and deliver healthcare solutions in US’ market PUNE, India, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Biorad Medisys, an Indian medical device manufacturer with a [...]
SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference
05/09/2025
DENVER, Sept. 04, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and [...]
Four Renowned Physicians Honored with Endowed Chairs at Providence Saint John’s Health Center
05/09/2025
Pioneering health care leaders noted for revolutionary advancements in medicine and research SANTA MONICA, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Providence Saint John’s Health Center honored four distinguished [...]
Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
05/09/2025
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced The Lancet Oncology published a study [...]
Avania Strengthens Leadership Team with Appointment of Four New Executives
04/09/2025
BILTHOVEN, Netherlands and BOSTON, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Avania , the leading global MedTech advisory and clinical development partner, is pleased to announce strategic leadership appointments of four [...]
The Ninth Circuit Orders California to Respond concerning its Mandatory DEI Indoctrination in Continuing Medical Education Courses, According to the Association of American Physicians and Surgeons
04/09/2025
TUCSON, Ariz., Sept. 04, 2025 (GLOBE NEWSWIRE) -- On September 2, the U.S. Court of Appeals for the Ninth Circuit ordered California to respond to a petition for rehearing challenging its diversity, equity, and [...]
Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
04/09/2025
BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam Capital Upsized and over-subscribed Series A total funding of $44 [...]
What’s Really Going On With Federal Funding? SMI and Travis Taylor Lead iC³® Summit Panel Discussion to Deliver Clarity in a Volatile Policy Era
04/09/2025
DALLAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Institutions, and organizations across the life sciences continuum are seeking clarity on how federal research and development (R&D) funding and critical resources can be [...]
Tevogen Shares Valuation of Key Assets and Potential Forecast For Pipeline Product Focused on EBV Associated Leukemia and Lymphomas
04/09/2025
The risk adjusted Net Present Value (rNPV) for TVGN 930 is estimated to exceed ~$250 million in the US alone. Covering five rare disease eligible indications, the accessible market in the US could be as high as 40,000 [...]
Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre
04/09/2025
Daix (France), New York City (New York, Etats-Unis), le 4 septembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva to Participate in Upcoming September Investor Conferences
04/09/2025
Daix (France), New York City (New York, United States), September 4, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the [...]

Pages